Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
Introduction: Enzymatic debridement for mixed depth and full thickness burns is gaining recognition as an important technique available to the burns surgeon. Reductions in blood loss, the need for autologous skin grafting and the number of wounds requiring surgical excision are among the benefits of...
Main Authors: | Neil Wickham, K. Skaria Alexander, Anthony Fletcher, Ciaran O’Boyle |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Scars, Burns & Healing |
Online Access: | https://doi.org/10.1177/2059513118821563 |
Similar Items
-
Therapeutic management of the enzymatic debriding agent Nexobrid® in the burn patient
by: Enrique Salmeron-Gonzalez, et al.
Published: (2018-01-01) -
To bleed or not to bleed? Case series and discussion of haemorrhage risk with enzymatic debridement in burn injuries
by: Saiidy Hasham, et al.
Published: (2023-04-01) -
Pain Management during Bromelain-Based Enzymatic Debridement (NexoBrid<sup>®</sup>) in a USA Adult Burn Center
by: Martin R. Buta, et al.
Published: (2023-12-01) -
Abstract: Retrospective Study Comparing Efficacy of Enzymatic Debridement with Nexobrid with Traditional Treatment in Circular Deep Burns in Prevention of the Compartment Syndrome
by: Enrique Salmeron-Gonzalez, MD, et al.
Published: (2018-09-01) -
Limitations to the use of bromelain-based enzymatic debridement (NexoBrid) for treating diabetic foot burns: a case series of disappointing results
by: Juan Enrique Berner, et al.
Published: (2018-12-01)